Docetero RTU 120 mg Injection 6 ml
₹12669*
MRP ₹15450
18% off
₹13132*
MRP ₹15450
15% CB
₹2318 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Docetero RTU 120 mg Injection 6 ml belongs to the class of 'anti-neoplastic/anti-cancer drugs', primarily used as a chemotherapy drug to treat cancers. It is effectively used in breast, lung, prostate, stomach, head/neck cancers. Cancer is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues.
Docetero RTU 120 mg Injection 6 ml contains Docetaxel, which belongs to the anticancer drugs. It works by slowing down cell growth. It is a cytotoxic agent, i.e., it prevents the cancer cells from rapidly dividing and spreading.
Docetero RTU 120 mg Injection 6 ml will be administered by a healthcare professional. Your doctor will decide the dosage depending on your medical condition. The common side effects of Docetero RTU 120 mg Injection 6 ml include pain/swelling at the injection site, headache, fatigue, dizziness, drowsiness, constipation, loss of appetite, indigestion, tearing of the eyes, nausea, vomiting, diarrhoea, insomnia (sleeplessness), fever (please inform your doctor if you have fever), muscle aches, and breathlessness. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Do not use or stop this medicine if the doctor did not advise you. Before starting Docetero RTU 120 mg Injection 6 ml, let your doctor know if you have any allergic reactions, medical history of liver or kidney diseases, heart diseases, blood pressure problems, fits, lung disorders, weak immune system, anemia, low white blood cell count, vision problems, and are receiving chemotherapy. Docetero RTU 120 mg Injection 6 ml is not indicated for use in pregnant and breastfeeding women. Docetero RTU 120 mg Injection 6 ml may make you feel dizzy and drowsy, hence do not drive or operate machinery. It is not recommended to consume alcohol along with Docetero RTU 120 mg Injection 6 ml. Docetero RTU 120 mg Injection 6 ml is not recommended for children below two years of age.
Docetero RTU 120 mg Injection 6 ml contains Docetaxel that belongs to the family of anticancer drugs. It works by slowing down cell growth. It is a cytotoxic agent and prevents cancer cells from rapidly dividing and spreading. Docetaxel may be used alone or in combination with other chemotherapy drugs to treat breast cancer that has spread to the tissues and lymph nodes (locally advanced breast cancer) and other parts (secondary breast cancer). It is also used in prostate cancer that does not respond to hormone treatment. It is further being investigated to treat small cell lung, ovarian, bladder, and pancreatic cancers.
Inform your doctor if you have any allergic reactions to Docetero RTU 120 mg Injection 6 ml or other medications. Before starting Docetero RTU 120 mg Injection 6 ml, let your doctor know if you have any medical history of allergic reactions, non-small cell lung cancer, liver or kidney diseases, heart diseases (congestive heart failure), blood pressure problems, fits, lung disorders (pulmonary effusions), weak immune system, anemia, low white blood cell count/thrombocytopenia, vision problems, and are already receiving chemotherapy. Docetero RTU 120 mg Injection 6 ml can affect the unborn baby when used in pregnancy. It may also have harmful effects on the breastfed infant when used by a lactating mother. Hence, Docetero RTU 120 mg Injection 6 ml is not indicated in pregnancy and breastfeeding women. If you are using Docetero RTU 120 mg Injection 6 ml, use reliable contraception forms to prevent pregnancy during the course. Docetero RTU 120 mg Injection 6 ml can make you feel dizzy and drowsy, thus affecting your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused. Avoid alcohol consumption while being treated with Docetero RTU 120 mg Injection 6 ml. Docetero RTU 120 mg Injection 6 ml is not recommended for patients younger than 18 years of age.
Drug-Drug Interaction: Docetero RTU 120 mg Injection 6 ml may interact with antibiotics (itraconazole, erythromycin, rifabutin, metronidazole, tinidazole), HIV drugs (ritonavir), drugs to treat chronic alcoholism (disulfiram), opioid medicines (codeine, hydrocodone), muscle relaxants (carisoprodol, cyclobenzaprine), and anti-allergic medicines (cetirizine, diphenhydramine).
Drug-Food Interaction: Grapefruit and its juice may interact with Docetero RTU 120 mg Injection 6 ml. Also, avoid alcohol consumption.
Drug-Disease Interaction: Docetero RTU 120 mg Injection 6 ml should be used with caution in cases of allergic reactions, non-small cell lung cancer, liver or kidney diseases, heart diseases (congestive heart failure), blood pressure problems, fits, lung disorders (pulmonary effusions), weak immune system, anemia, low white blood cell count/thrombocytopenia, vision problems.
Cancer: It is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues. There are two types of cancer: benign (localized) and metastatic (spread to the whole body). Cancer growth can be prevented by chemotherapy (by strong antibiotics), radiation, and stem cell therapy.
Breast cancer: It is a type of cancer that develops in breast cells stimulated by a female sex hormone called estrogen. Breast cancer may form in lobules (glands that produce milk), ducts of the breast (the pathway that brings milk from glands to the nipple), in the fatty tissue, or the fibrous connective tissue within the breast. Symptoms include a lump in the breast or tissue thickening which feels different than the normal surrounding tissues, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, unexplained change in shape, size, or appearance of the breast, and a lump or swelling under the arm.
Alcohol
Unsafe
It is unsafe to consume alcohol while using Docetero RTU 120 mg Injection 6 ml since it may cause increased dizziness and drowsiness. Please consult your doctor for more information.
Pregnancy
Unsafe
It is unsafe to use Docetero RTU 120 mg Injection 6 ml in pregnancy and can have harmful effects on the unborn baby. Use reliable forms of contraception to prevent pregnancy while using Docetero RTU 120 mg Injection 6 ml.
Breast Feeding
Unsafe
Docetero RTU 120 mg Injection 6 ml is not recommended during breastfeeding since it may be unsafe for the breastfed infant. Please seek medical advice if you are a nursing mother before starting Docetero RTU 120 mg Injection 6 ml.
Driving
Unsafe
Docetero RTU 120 mg Injection 6 ml causes dizziness and drowsiness that may affect your ability to drive. Do not drive or operate machinery if you experience unmanageable side effects with Docetero RTU 120 mg Injection 6 ml.
Liver
Caution
Please let your doctor know if you have any history of liver diseases or hepatic impairment. Before being treated with Docetero RTU 120 mg Injection 6 ml, your doctor may advise you of blood tests to check your liver functioning.
Kidney
Caution
Please let your doctor know if you have any history of kidney diseases before starting Docetero RTU 120 mg Injection 6 ml.
Children
Unsafe
Safety and efficacy of Docetero RTU 120 mg Injection 6 ml have not been established in patients younger than 18 years.
Country of origin
Manufacturer/Marketer address
Product Substitutes